Model Number 610-0001 |
Device Problems
Improper or Incorrect Procedure or Method (2017); Device Dislodged or Dislocated (2923)
|
Patient Problems
Corneal Scar (1793); Corneal Clouding/Hazing (1878); Keratitis (1944); Visual Impairment (2138); Burning Sensation (2146)
|
Event Date 10/28/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
The device history record (dhr) for this manufacturing lot was reviewed and the device met all release criteria and there were no discrepancies or unusual findings that relate to the reported event.Inlay decentration is listed in the device labeling as a known complication of corneal inlay surgery.Dlk is also listed in the device labeling and is commonly associated with corneal flap procedures.The instructions for use for the raindrop near vision inlay specifies that the corneal flap must be a minimum of 150 microns thick; however, the patient's flap was only 120 microns.The flap thickness and off-label use of celluvisc may have been contributory to the reported issues.(b)(4).Date emdr submitted to fda: 12/15/2016.
|
|
Event Description
|
Corneal inlay implantation was performed on (b)(6) 2016 on the patient's left eye.During corneal flap creation using a femtosecond laser, the patient inadvertently received a flap thickness of 120 microns even though the surgeon ordered 180 microns.At the end of the procedure, several drops of celluvisc were instilled on the flap.At the one-day postoperative visit, the patient complained of blurry vision and stinging sensation.The inlay had decentered slightly inferiorly and the patient was diagnosed with trace diffuse lamellar keratitis (dlk).The postoperative steroid regimen included durezol and vigamox and artificial tears as needed.The patient's preoperative best corrected distance visual acuity (bcdva) was 20/20.New information was received on (b)(6) 2015 indicating that the inlay will be explanted due to decentration.Additional information was requested and on (b)(6) 2016 the surgeon provided the following update.At onset, the patient's postoperative bcdva decreased to 20/50, but improved to 20/15 on (b)(6) 2016.On (b)(6) 2016, the flap was irrigated and the inlay was removed and replaced with a new inlay in order to address both dlk and inlay decentering, which was described as slightly inferior.The dlk resolved.
|
|
Manufacturer Narrative
|
The explanted inlay was returned to the manufacturer and subjected to visual microscopic inspection.The findings revealed that the inlay was folded and dehydrated.As a result, no dimensional measurements could be performed.Complaint (b)(4).Date esmdr submitted: 03/02/2017, reference mdr# 3005956347-2017-00004 for the replacement inlay.
|
|
Event Description
|
An adverse event occurred with the replacement raindrop corneal inlay that was implanted in the patient's left eye on (b)(6) 2016.Reference mdr# 3005956347-2017-00004 which was filed for the replacement inlay for this same patient.
|
|
Manufacturer Narrative
|
(b)(4).Reference mdr# 3005956347-2017-00004 for the events involving the second inlay.
|
|
Event Description
|
The following new information was provided on july 26, 2017.At last examination on (b)(6) 2017, the patient's bcdva improved to 20/20 with trace central corneal haze and minimal epithelial in-growth.There is no further patient follow-up scheduled.
|
|
Search Alerts/Recalls
|